Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Co-dergocrine mesylate 4.5mg tablet |
Is a |
Product containing dihydroergocornine and dihydroergocristine and dihydroergocryptine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
vasoconstricteur |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Co-dergocrine |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydroergocornine |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydroergocryptine (substance) |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dihydroergocristine |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator (substance) |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Respiratory system agent (substance) |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
Has manufactured dose form |
Oral tablet |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
Is a |
Co-dergocrine mesylate |
false |
Inferred relationship |
Some |
|
|
Co-dergocrine mesylate 4.5mg tablet |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Some |
|
|